SCHEMBL12623218

SCHEMBL12623218

c1ccc(-c2oc3cccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c3c2-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 1/20 0.41
▸ PLA2G4A P47712 1/20 0.41
▸ ABCG2 Q9UNQ0 4/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ GPR84 Q9NQS5 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ ANO1 Q5XXA6 1/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12623222 0.96 PLA2G2A (0.40) PLA2G2APLA2G4AABCG2PTGS2GPR84
SCHEMBL23426633 0.89 GPR84 (0.40) ABCG2GPR84ALDH1A1MAPTESR1
SCHEMBL29598588 0.88 PLA2G2A (0.43) PLA2G2APLA2G4AABCG2PTGS2ALDH1A1
SCHEMBL22954101 0.88 PLA2G2A (0.43) PLA2G2APLA2G4AABCG2PTGS2ALDH1A1
SCHEMBL12623241 0.87 ENPP3 (0.41) PLA2G2APLA2G4AABCG2ALDH1A1MAPT
SCHEMBL25159444 0.86 S1PR5 (0.38) PLA2G2APLA2G4AABCG2PTGS2GPR84
SCHEMBL12623253 0.86 PLA2G2A (0.43) PLA2G2APLA2G4AABCG2PTGS2ALDH1A1
SCHEMBL27010498 0.85 GPR84 (0.39) ABCG2GPR84ALDH1A1MAPTESR1
SCHEMBL23426624 0.85 PLA2G2A (0.38) PLA2G2APLA2G4AABCG2GPR84ALDH1A1
SCHEMBL23426499 0.85 ALOX5 (0.39) ABCG2GPR84ALDH1A1MAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150162536-A1 ELECTROACTIVE MATERIALS DU PONT (US) 2015-06-11 — — US disclosed
US-20150162536-A1 ELECTROACTIVE MATERIALS DU PONT (US) 2015-06-11 — — US disclosed
US-8992800-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2015-03-31 — — US disclosed
US-8992800-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2015-03-31 — — US disclosed
US-20130248835-A1 ELECTROACTIVE MATERIALS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-09-26 — — US disclosed
US-20130248835-A1 ELECTROACTIVE MATERIALS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-09-26 — — US disclosed
US-8460583-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2013-06-11 — — US disclosed
US-8460583-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2013-06-11 — — US disclosed
US-20130001539-A1 ELECTROACTIVE MATERIALS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-01-03 — — US disclosed
US-20130001539-A1 ELECTROACTIVE MATERIALS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-01-03 — — US disclosed
US-8308988-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2012-11-13 — — US disclosed
US-8308988-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2012-11-13 — — US disclosed
US-20110101310-A1 ELECTROACTIVE MATERIALS E.I. DU PONT DE NEMOURS AND COMPANY 2011-05-05 — — US disclosed
US-20110101310-A1 ELECTROACTIVE MATERIALS E.I. DU PONT DE NEMOURS AND COMPANY 2011-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150162536-A1 ELECTROACTIVE MATERIALS KCNN4, SCO2, SYNGR2 PLA2G2A 2947/4885PLA2G4A 3726/4885ABCG2 4691/4885
US-20130001539-A1 ELECTROACTIVE MATERIALS KCNN4, SCO2, SYNGR2 PLA2G2A 2947/4885PLA2G4A 3726/4885ABCG2 4691/4885
US-20110101310-A1 ELECTROACTIVE MATERIALS KCNN4, SCO2, SYNGR2 PLA2G2A 2947/4885PLA2G4A 3726/4885ABCG2 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback